SHIRLEY GREENWAY: Open Payments
NPI 1033881727 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $372 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Boston Scientific Corporation | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| CVRx, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
Products named: LEQVIO, JARDIANCE, REPATHA, BodyGuardian, Barostim Neo System, WAINUA, ENTRESTO, CAMZYOS.
Industry payments across GA — which companies pay providers there.
